Several prominent authors published a number of reviews on the hypotheses that may be suitable for the explanation of the remarkable tissue specificity of early cancers (HBOC) in BRCA1 and BRCA2 heterozygous carriers (Figure 1). This evidence concerns the gene BRCA1 and cancer.